In order to prepare
The chemical structure of mammalian hypothalamic luteinizing hormone-releasing hormone (LHRH) was determined as pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 in hogs (Matsuo et al., 1971) and sheep (Burgus et al., 1972) .
Recently, LHRHs with different structure from mammalian LHRH were found in chicken (Miyamoto et al., 1982; King, 1982a, b) and salmon (Sherwood et al., 1983) hypothalami. Moreover, 2 kinds of LHRH were isolated from chicken hypothalami with different structure and biopotency (Miyamoto et al., 1984) . On the other hand, LHRH and LHRH-like ma-terials have been recently demonstrated in extrahypothalamic sites. Among them, the LHRH-like substance in the pineal gland has been reported to have different immunoreactivity and cation exchanger chromatographic properties from those of hypothalamic LHRH (Millar and Tobler, 1981; Piekut and Knigge, 1981; Piekut, 1983) . These results revealed the molecular multiplicity of LHRH. Many kinds of polyclonal anti-LHRH sera have been prepared and contributed to the studies on LHRH (Arimura et al., 1973 (Arimura et al., , 1975 Copeland et al., 1979) , however, they could be used only for limited species because of strict species specificity, and also could not detect possible precursors because of the special structure of LHRH in the Nand C-terminals. Recently, monoclonal antibodies which were prepared by hybridoma technology (Kohler and Milstein, 1975) with highly specific binding sites, have been used widely as immunochemical probes. Natural LHRH analogues have a common sequence near the N-terminal region of the molecule. We set out to produce a monoclonal antibody which recognized such a region. In this report, we describe its preparation, characteristics and immunohistochemical application. Antigen preparation Synthetic LHRH (free acid) was conjugated to Tg by the EDC method (Davis and Preston, 1981) . Briefly, to 1mg of LHRH (free acid) in 0.2ml of 10mM phosphate buffer (PB), pH 5, 5.3mg of EDC in 0.1ml distilled water was added. After 2min, the mixture was added to 5 mg Tg in 0.2ml of 0.1M PB, pH 8, and incubated overnight at room temperature. The reaction mixture was dialyzed against phosphate buffered saline (PBS: 0.01M sodium phosphate and 0.14M NaC1 containing 0.05% sodium azide, pH 7.5). The recovery and conjugation rates were calculated from 131I-Tg and 125I-LHRH added to the reaction system in trace amounts. The recovery rate of Tg was 85%, and the molar ratio of LHRH: Tg was 35: 1. Protein A affinity chromatography of anti-LHRH Protein A affinity chromatography was performed according to Ey et al. (1978) . Two and half ml of ascitic fluid was diluted with the same volume of 0.1M sodium phosphate, pH 8.0 and adjusted to pH 8.1 with 1M Tris-HC1, pH 9.0. The sample was applied to a Protein A-Sepharose CL-4B column equilibrated with 0.5 M sodium phosphate, pH 8.0, washed with 30ml of the same buffer. Then IgG subclass were serially eluted with 0.1M citrate buffers of pH 6.0, 5.5, 4.5 and 3.5 while monitoring the absorbance at 280nm. (1984) and Mason et al. (1982) . Monoclonal anti-HRPO ascitic fluid was precipitated with halfsaturated ammonium sulfate and dialyzed against saline, then 1mg of HRPO dissolved in 5ml of BSA-PBS was added to 1ml of monoclonal anti-HRPO solution (6.2mg in BSA-PBS).
This solution was diluted at 1:50 for immunostaining. 
Preparation of monoclonal antibodies
The spleen cells from a BALB/c donor mouse immunized with LHRH-Tg were fused to the X63. Ag8. 653 mouse myeloma. Two weeks after cell fusion, colonies of hybrid cells were visible in 64.5% of total wells in 24 plates. Among them, only one supernatant showed positive binding activity to 125I-Tyr-LHRH . By the limiting dilution cloning, 79% of single colony-containing wells showed positive reaction. This clone is named HAC-MMO2-01MSM84 (LRH 13).
For the immunohistochemical study, mouse monoclonal anti-HRPO was also produced. In the case of HRPO, 54.8% of 16 plates had a visible colony. Three weeks after fusion, 11 positive wells were found. Cell lines were established from 5 clones.
Binding activity of LRH13 ascitic fluid
As shown in Fig. 1 Binding of LRH13 to LHRHs of different species So far, 4 kinds of LHRH have been found, i. e. mammalian LHRH, chicken LHRH-I, chicken LHRH-II, and salmon LHRH. Fig. 3 shows the crossreactivity of these non-mammalian LHRHs and LHRH analogues with free terminal amino acids. If we calculate their relative affinities to that of LHRH from ED50 of their slopes, >LHRH< (12.9), >LHRH (10.4), salmon LHRH (8.3), and chicken LHRH-I (6.0) all had similar binding activity to LRH13, and were higher than LHRH and LHRH<. The second group was LHRH< (1.6) and LHRH (1). Chicken LHRH-II (0.3) had the weakest activity.
Affinity of LRH13 Fig. 4 shows the Scatchard plot and the saturation curve drawn from a binding experiments with LHRH. The affinity constant (Ka) of LRH13 ascitic fluid calculated to the organum vasculosum of the lamina terminalis (OVLT) in the light microscopic examination. Rat olfactory bulb also had a few LHRH perikarya. In chicken, LHRH immunoreactive perikarya were found in the septal and preoptic area. In Japanese quail, immunoreactive perikarya were found in the same area as in chicken, but their number was smaller than the former. In rainbow trout, there were found scattered immunoreactive LHRH perikarya in the ventral area of the telencephalon, though not so many. Most of the cell bodies observed in these animals were bipolar. In rat and mouse, LHRH immunopositive fibers and terminals were in the OVLT, but the greatest amounts of LHRH were distributed laterally in the median eminence, whereas the anterior and posterior regions of the median eminence had the largest indicate the universal structure of LHRH without species specificity (King and Millar, 1980) . However, the potencies of LHRH were different depending on the animal species (Jackson, 1971a and b; King and Millar, 1980; Hattori et al., 1980) , and recent elucidation of the chemical structure of LHRHs isolated from chicken (Miyamoto , 1982 and 1984; King, 1982a and b) and salmon (Sherwood et al., 1983) indicated the presence of species specificity of LHRH. The variable region of LHRH amino acid sequence related to species specificity is near the C-terminal region of the molecules. According to Momany (1976a Momany ( , 1976b Momany ( and 1978 , the configuration of mammalian LHRH in solution is loop-like with N-and C-terminals in adjacent positions. Many investigators have carried out studies on the antibody binding site based on this configuration (Millar and Tober, 1981; Knigge et al., 1978 LHRH is also spliced from big precursor peptide (Curtis and Fink, 1983 Curtis et al., 1983) and both terminals are modified before secretion. Knigge and coworkers (1978) suggested that we must consider the possibility that neurohormones are present in different physiochemical states in perikarya, axons and terminals. Up to date, many kinds of anti-LHRH antisera have been prepared and characterized.
But as they were produced by the conventional method, they were mixtures of antibodies with different binding sites. This made their characterization difficult. Most of the antisera recognize both N-and C-terminals, especially around the C-terminal region, and bound only the complete molecule of mammalian, LHRH. So we tried to prepare a monoclonal anti-LHRH which could distinguish conservative amino acid sequence near the N-terminal of native LHRHs in order to apply it to the studies on LHRH in a wide variety of animal species. It should also be useful in the study of LHRH precursor peptides because its binding site does not include pyroGlu1 and Gly-NH210.
To direct the recognition site around the central to the N-termianl region, we prepared C-terminal free LHRH (LHRH free acid) and bovine thyroglobulin conjugates by EDC method.
After the first innoculaton and booster shot, intensive immunization was carried out from 4 days before fusion according to Stalin et al. (1983) for high specific fusion. But we could get only one positive clone. An ascitic fluid (LRH 13) was obtained by transplantation of this clone to mice. When LRH13 was applied on a Protein A-Sepharose column and eluted stepwise with the elution buffers of different pH, the antibody was exclusively eluted at pH 3.5. This indicated that our monoclonal antibody belong to the subclass of immunoglobulin G,.
A competitive binding experiment using LHRH analogues and fragments listed in Table 1 indicated that the binding site of LRH13 seems to be the sequence around serine of the decapeptide because N-terminal region fragments (Glyl-His2 and GlylTrp3) and a C-terminal region fragment (Tyr5-G1n" fragment) failed to inhibit the 3H-LHRH binding to this monoclonal anti-LHRH, whereas Gly1-Ser4 and Gly1-Tyr5 fragments which both contained serine as the 4th amino acid, could inhibit it. But the Gly'-Tyr5 fragment had higher affinity for the antibody than Gly1-Ser4 fragment, indicating that tyrosine, the 5th amino acid of the decapeptide is also important for binding, with good affinity for LRH13. This is also supported by the fact that 1251-LHRH, in which radioiodine was labelled on tyrosine moiety, bound only weakly to LRH13. LRH13 bound well with mammalian, chicken and salmon LHRHs. However, chicken LHRH-II showed lower affinity. According to Miyamoto et al. (1982 Miyamoto et al. ( , 1984 , chicken LHRH-II is substituted for three amino acids, namely His', Trp7, Tyr8-LHRH. This fact also shows that the 5th amino acid of mammalian LHRH, tyrosine, affects the binding considerably. We did not examine whether the N-terminal side amino acids, from 1 to 3, affected the binding. But when we examined the binding with free N-and/or Cterminal-LHRH analogues, those with free N-terminal showed a higher affinity for the antibody. These results indicated that neither N-terminal nor C-terminal was the binding site of LRH13. In our antigen, LHRH was conjugated at C-terminal to thyroglobulin. Therefore, this loop-like configuration was distorted and may be slightly straightened after conjugation. LHRH with free N-terminal may have a rather straight configuration, and chicken LHRH-I and salmon LHRH may have a similar configuration to free N-terminal LHRH. Precursor peptides of LHRH should have a rather straight configuration because N-and C-terminals are connected to other amino acids (Seeburg and Adelman, 1984 must be favorable to such precursor peptides. For immunohistochemical visualization, recently an unlabelled method using PAP complex, has been in use. When we use a mouse monoclonal antibody for this purpose, anti-peroxidase which is employed to prepare the PAP complex, should belong to the same animal species. We therefore also prepared mouse monoclonal antibody to HRPO. Monoclonal mouse PAP complex was prepared according to Mason et al., (1982) and Landsdrop et al., (1984) and could be diluted to 1: 50-100 for immunohistochemical staining.
Distribution of the immunoreactive materials in the brain differed according to the antiserum used for staining (Piekut and Knigge, 1981 and 1982) . When we used LRH13, the main population of immunopositive cell bodies was in the preoptic and medial septal region and immediately adjacent to OVLT in the rodents. Occasionally, we also found positive cell bodies in the olfactory bulb in the rat. Immunopositive fibers were in the OVLT and median eminence. In avian species, the areas in which immunoreactive perikarya were distributed were from the septal to the preoptic area, and terminals were in the median eminence. In rainbow trout, we could observe scattered immunoreactive perikarya in the ventral area of the telencephalon even in immature fish. Immunoreactive terminals directly reached the area in the pituitary where there was a gonadotroph population.
In general, the intensity of staining in the median eminence seemed to be slightly less than that of the conventional polyclonal anti-LHRH sera raised in rabbits, but no problems were encountered in light microscopic observation.
In most cases with polyclonal anti-LHRHs, pretreatment of animals with colchicine to accumulate LHRH in the perikarya is necessary for positive staining of cell bodies. We could obtain intensive staining of cell bodies in the rodent, avian and fish brains without colchicine pretreatment. These facts seem to indicate that not only completed LHRH but also LHRH precursors in the perikarya were stained with LRH13.
Since White et al., (1974) reported immunoreactive and bioactive LHRH in the bovine pineal gland, such LHRH-like immunopositive substance has also been reported in the rat gland (Knigge and Piekut, 1978; Piekut and Knigge, 1981 and 1982; Pevet et al., 1980; Piekut, 1982) . Using antisera generated against different conjugates (Piekut and Knigge, 1981) and different analogs of the LHRH molecule (Piekut and Knigge, 1982) , it has been demonstrated that the immunoreaction product seen in the rat pineal gland is immunologically different from that of hypothalamic LHRH. Moreover, Piekut (1983) reported that the pH of the fixative contributes substantially to the amount and distribution of LHRH visualized immunohistochemically in the brain, and the pineal LHRH-like material is a bigger molecule than hypothalamic LHRH (Millar et al., 1977; Pevet et al., 1980) . Our LRH13 could visualize the LHRH-like material in the rat pineal gland without any modification of the method. Because treatment with the acid fixation solution induce conformational changes in the secondary or tertiary structures of peptides (Berod et al., 1981; Hoffman et al., 1978; Van Leeuwen, 1977) , it was possible that our immunohistochemical products in the brain and the pineal gland may contain a precusor type of LHRH or configurationally changed LHRH-like material as well as the decapeptide, LHRH.
The results of immunohistochemical staining seem to indicate high LHRH specificity and wide crossreactivity over animal classes of LRH 13 to the possible precursor peptides of LHRH. From such properties of this monoclonal antibody, it can be applied not only for immunohistochemical studies but also for studies on biosynthesis
